Pierre Morange, MD, PhD

Aix-Marseille University, France

Pierre-Emmanuel Morange, a medical doctor, is a Hematology professor and the director of the Hematology department at the University Hospital of Marseille, France. He has a specific interest in Hemostasis and serves as the team leader for a research group at the French National Institute of Health and Medical Research (Inserm). The primary research project of his team focuses on identifying the genetic factors associated with thrombosis and discovering new thrombophilias. He has authored over 300 articles published in PubMed.

Presentation(s):

• OC 07.1 - The clearance receptor CLEC4M regulates plasma factor V levels through factor V binding and internalization

  Saturday, June 22, 2024
  13:00 – 13:15 ICT

• OC 08.1 - The rare Ser569Ser (c.1707C>T) PROS1 variant induces a frameshift due to a splicing defect and is enriched in patients with venous thrombosis

  Saturday, June 22, 2024
  13:00 – 13:15 ICT

• OC 08.2 - Genome-wide meta-analyses and integrative multi-omics analysis of endogenous thrombin generation potential in the CROSSLINK consortium

  Saturday, June 22, 2024
  13:15 – 13:30 ICT

• SSC 07.3 - Diagnosis and management of thrombophilias

  Sunday, June 23, 2024
  16:50 – 17:05 ICT

• OC 37.2 - Non-canonical regulation of Endoglin plasma levels by common variants: new molecular and clinical perspectives in hemostasis and thrombotic risk

  Monday, June 24, 2024
  09:45 – 10:00 ICT

• PB0954 - Co-occurrence of extremely rare ENG S484S and V504M variants in two independent women with unexplained venous thrombosis.

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0940 - Polygenic risk score predictor of pulmonary embolism among those with a deep vein thrombosis: the INVENT Consortium

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 54.1 - `Genome-Wide Investigation of Exogenous Female Hormones, Genetic Variation, and Venous Thromboembolism Risk: the INVENT Consortium

  Tuesday, June 25, 2024
  09:30 – 09:45 ICT

• OC 76.3 - Landscape of natural variants affecting the N-glycosylation of antithrombin: biological and clinical impact

  Wednesday, June 26, 2024
  10:45 – 11:00 ICT